IL6 and chronic obstructive pulmonary disease: Previous studies [34,35] have further emphasized the role of IL-6 as a central mediator of systemic inflammation in COPD, with elevated serum levels being significantly associated with reduced lung function, increased symptom severity, and a higher risk of acute exacerbations.